Clinical Trials in Belgium / NCT05826067
Recruiting Observational

Study of E. Coli Isolates From Recurrent Urinary Tract Infections

NCT05826067 · tracked via the Priya Life Science Belgium tracker
Phase
Observational
Started
2023-04-20
Last updated
2024-12-10

Condition(s) studied

Urinary Tract InfectionsPatients With Suprabubic CatheterPatients With Nephrostomy Catheter

Investigational drug(s) / intervention(s)

collection of bacterial strains

collection of bacterial strains: Urine (and blood) samples will be collected following SOC procedures for diagnostic purposes, at each visit of the patient (initial visit, follow up study or visit for new episode. For patients needing a catheter, urine sample will be collected before the insertion of the catheter, and before renewal of the catheter. Catheter tips will also be collected and sonicated to isolate bacteria. E. coli will be stored for analysis.

Study summary

Prospective study aiming at collecting clinical Escherichia coli isolates from patients with recurrent urinary tract infection; samples to be collected during routine procedures.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * patients hospitalized for urinary tract infection, with or without neurological disorders (spina bifida, MS, paraplegic patients) or ambulatory patients diagnosed with a urinary tract infection when the identified causative agent is E. coli * patients who have or are planned to undergo the insertion of a suprapubic catheter * patients who have or are planned to undergo the insertion a nephrostomy catheter Exclusion Criteria: patients * refusing the planned treatment * with therapy compliance * pregnant women * who do not consent to participate

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Cliniques universitaires Saint Luc Brussels Belgium Recruiting

More Université Catholique de Louvain trials in Belgium

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05826067 on ClinicalTrials.gov ↗ ← All trials in Belgium